EGFR plasma mutation in prediction models for resistance with EGFR TKI and survival of non-small cell lung cancer
This study aims to clarify the prognostic role of epidermal growth factor receptor (EGFR) mutations in plasma of non-small cell lung cancer (NSCLC) for resistance to tyrosine kinase inhibitor (TKI), in correlatio...